Pharmaceutical combination formulation comprising Lobeglitazone Empagliflozin and Metformin as active ingredient
KR20260122692A · Application publication visible
immortal.lifeExplore source-linked longevity patent families and topic connections associated with the applicant name CHONG KUN DANG PHARMACEUTICAL CORP [KR].
This independent page groups EPO bibliographic records in which this name appears as an applicant or assignee. It is not a corporate profile, ownership opinion, portfolio valuation or ranking.
KR20260122692A · Application publication visible